BloodHub

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

BloodHub - overview

Established

2010

Location

Phoenix, AZ, US

Primary Industry

Software

About

Founded in 2010, and based in Arizona, US, BloodHub is a software company that provides integrated supply chains for blood suppliers, reference labs, and hospitals. Michael Pandelak is the founder and CEO. In October 2022, it joined InVita Healthcare Technologies to accelerate integrated solutions for blood centers. The company has written and managed applications that span the entire blood management process from recruitment and collections to manufacturing, testing, and distribution.


It provides solutions for BloodRelay, orders, logistics, and BloodBill. BloodRelay can achieve automate IRL workflows including patient and sample management, testing, and reporting. From high-priority STAT orders to complex lab workups, America’s blood bankers rely on their paperless orders.


Current Investors

InVita Healthcare Technologies, Inc.

Primary Industry

Software

Sub Industries

Medical Software

Website

www.bloodhub.com

Verticals

HealthTech

Company Stage

Add-on

Total Amount Raised

Subscriber access only

BloodHub - deals

Deals TypeDeal StatusTarget (s)Deal DateInvestor(s)Seller(s)Deal size (Mn)Enterprise value (Mn)Post-money valuation (Mn)EBITDA multiple (x)Revenue multiple (x)Lead partner (s)
Add-onCompletedBloodHub-

Displaying 1 - 1 of 1

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.